Literature DB >> 4087165

Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.

T Terasaki, Y Sugiyama, T Iga, Y Sawada, M Hanano.   

Abstract

Drug distribution kinetics in a noneliminating organ or tissue has been mathematically examined. The homogeneous (well-stirred) model regards the noneliminating organ or tissue as a homogeneous compartment in which the drug is equilibrated with that in the blood leaving the organ or tissue. The nonhomogeneous (tube) model views the noneliminating organ or tissue as comprising a number of parallel cylindrical tubes containing binding sites distributed homogeneously along these tubes. These two models are examined, considering the pseudo-distribution equilibrium phase after bolus injection and a linear binding condition. Although both models predict a similar tissue distribution under a variety of conditions, significant differences exist in the predictions of various pharmacokinetic parameters as a function of the drug distribution, such as blood flow, organ volume, slope of the terminal phase, and the tissue-to-blood partition coefficients. The predictability and limitations of these two models are explored. Distribution characteristics of the two models are also examined for adriamycin, actinomycin D, tetrachlorobiphenyl, hexachlorobiphenyl, digoxin, and ethoxybenzamide; no difference is observed. It is concluded that the assumption of a homogeneous (well-stirred) compartment is suitable for describing the drug distribution kinetics of these drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087165     DOI: 10.1007/BF01065656

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  16 in total

Review 1.  A review of the applications of physiologically based pharmacokinetic modeling.

Authors:  K J Himmelstein; R J Lutz
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant.

Authors:  T Terasaki; T Iga; Y Sugiyama; M Hanano
Journal:  J Pharm Pharmacol       Date:  1982-09       Impact factor: 3.765

3.  Binding of quinidine in serum and heart from normal and anuric rats, and the significance for distribution.

Authors:  D Fremstad; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1979-09-01       Impact factor: 5.858

4.  Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

Authors:  J A Jansen
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

5.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

6.  Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

7.  Studies on the uptake and binding of propranolol by rat tissues.

Authors:  D W Schneck; J F Pritchard; A H Hayes
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

8.  Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs.

Authors:  T Terasaki; T Iga; Y Sugiyama; M Hanano
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

9.  Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in rat.

Authors:  J H Lin; M Hayashi; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1978-08

10.  A model for the kinetics of distribution of actinomycin-D in the beagle dog.

Authors:  R J Lutz; W M Galbraith; R L Dedrick; R Shrager; L B Mellett
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  4 in total

1.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.

Authors:  R E Oliver; A C Heatherington; A F Jones; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

3.  The assessment of bioavailability in the presence of nonlinear elimination.

Authors:  S D Hall; C B McAllister; G R Wilkinson
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

4.  The uptake and elution of lignocaine and procainamide in the hindquarters of the sheep described using mass balance principles.

Authors:  R N Upton; W B Runciman; L E Mather; C F McLean; A H Ilsley
Journal:  J Pharmacokinet Biopharm       Date:  1988-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.